Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

Overview

Patients with a ureteral or kidney stone that causes symptoms, like pain, frequently have small kidney stones that don't cause symptoms. If these small kidney stones are determined to be asymptomatic (not causing any problems or pain), then most urologists will simply remove the symptomatic ureteral stone and leave the additional stones in the kidneys. However, symptomatic kidney stones started as small stones that didn't cause symptoms. This means that the small stones remaining in the patient's kidney may cause problems later. The purpose of our research is to test if removing small stones from the kidney prevents future stone episodes.

Full Title of Study: “Randomized Controlled Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 2022

Interventions

  • Procedure: Symptomatic stone removal
    • Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy
  • Procedure: Asymptomatic kidney stones and ureteral stone removed
    • Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy

Arms, Groups and Cohorts

  • Other: Symptomatic stone removal
    • Group 1 will receive the standard treatment of having only the symptomatic stone removed
  • Other: Asymptomatic kidney stones and symptomatic stone removed
    • Group 2 will include the step of having the asymptomatic kidney stones removed in addition to the symptomatic stone

Clinical Trial Outcome Measures

Primary Measures

  • Relapse of stone disease on the study side
    • Time Frame: annually up to 5 years after stone removal surgery
    • Radiological evidence of significant growth in the size of any pre-existing stone Return for stone removal surgery on the study side Passage of a stone with pain symptoms on the study side resulting in an emergency department visit

Participating in This Clinical Trial

Inclusion Criteria

  • Scheduled to undergo surgery (URS or PCNL) for a primary stone. – Computed tomography (CT) exam within the 90-day pre-operative period – Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone. – Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones – Able to give informed consent – Age 21 years or older Exclusion Criteria:

  • Inability to give informed consent – Age less than 21 years – Stones not visible on KUB or CT – Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney) – Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the – subject at significant risk, confound the study results, or interfere significantly with the subject's – participation in the study. – Unwilling to participate.

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Indiana Kidney Stone Institute
  • Collaborator
    • University of Washington
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • James E Lingeman, MD, Principal Investigator, Indiana University Health

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.